Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat dermatological disorders.
Latest News
Dermatology
Blueberry is committed to the development of innovative new therapies for the treatment of common dermatological disorders.
Nanomedicine
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
News
Ringworm of the scalp: tinea capitis
Written by Dr Heather Davies-Strickleton, Senior Analytical Scientist Despite its name, ringworm is not caused by worms, it’s caused [...]
John Ridden invited to showcase Blueberry’s success at BioCap
Blueberry CEO John Ridden has been invited to speak at BioCap this October at Alderley Park. John is pleased to [...]
A Blueberry case study
In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.